vs
Side-by-side financial comparison of AMREP CORP. (AXR) and Cytosorbents Corp (CTSO). Click either name above to swap in a different company.
AMREP CORP. is the larger business by last-quarter revenue ($14.6M vs $9.2M, roughly 1.6× Cytosorbents Corp). AMREP CORP. runs the higher net margin — 21.6% vs -59.5%, a 81.1% gap on every dollar of revenue. On growth, AMREP CORP. posted the faster year-over-year revenue change (93.8% vs 0.9%). AMREP CORP. produced more free cash flow last quarter ($5.4M vs $-4.9M). Over the past eight quarters, Cytosorbents Corp's revenue compounded faster (1.3% CAGR vs -13.6%).
AMREP Corporation is a real estate and media services company based in Princeton, New Jersey, in the United States. It was founded in 1961 as The American Realty and Petroleum Corporation.
CytoSorbents Corporation is a publicly traded company located in Princeton, New Jersey.
AXR vs CTSO — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $14.6M | $9.2M |
| Net Profit | $3.1M | $-5.5M |
| Gross Margin | — | 73.7% |
| Operating Margin | 20.6% | -47.5% |
| Net Margin | 21.6% | -59.5% |
| Revenue YoY | 93.8% | 0.9% |
| Net Profit YoY | 338.9% | 27.4% |
| EPS (diluted) | $0.58 | $-0.09 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $14.6M | — | ||
| Q4 25 | $9.4M | $9.2M | ||
| Q3 25 | $17.9M | $9.5M | ||
| Q2 25 | $11.2M | $9.6M | ||
| Q1 25 | $7.5M | $8.7M | ||
| Q4 24 | $11.9M | $9.2M | ||
| Q3 24 | $19.1M | $8.6M | ||
| Q2 24 | $19.5M | $8.8M |
| Q1 26 | $3.1M | — | ||
| Q4 25 | $1.2M | $-5.5M | ||
| Q3 25 | $4.7M | $-3.2M | ||
| Q2 25 | $3.9M | $1.9M | ||
| Q1 25 | $717.0K | $-1.5M | ||
| Q4 24 | $4.0M | $-7.6M | ||
| Q3 24 | $4.1M | $-2.8M | ||
| Q2 24 | $4.1M | $-4.3M |
| Q1 26 | — | — | ||
| Q4 25 | — | 73.7% | ||
| Q3 25 | — | 70.3% | ||
| Q2 25 | — | 70.9% | ||
| Q1 25 | — | 71.1% | ||
| Q4 24 | — | 68.4% | ||
| Q3 24 | — | 61.0% | ||
| Q2 24 | — | 73.5% |
| Q1 26 | 20.6% | — | ||
| Q4 25 | 11.9% | -47.5% | ||
| Q3 25 | 34.4% | -30.2% | ||
| Q2 25 | 31.7% | -37.6% | ||
| Q1 25 | 5.7% | -44.5% | ||
| Q4 24 | 26.4% | -37.1% | ||
| Q3 24 | 26.1% | -56.1% | ||
| Q2 24 | 23.9% | -40.4% |
| Q1 26 | 21.6% | — | ||
| Q4 25 | 12.8% | -59.5% | ||
| Q3 25 | 26.3% | -33.4% | ||
| Q2 25 | 34.8% | 20.2% | ||
| Q1 25 | 9.5% | -16.9% | ||
| Q4 24 | 33.9% | -82.7% | ||
| Q3 24 | 21.3% | -32.1% | ||
| Q2 24 | 21.2% | -48.6% |
| Q1 26 | $0.58 | — | ||
| Q4 25 | $0.22 | $-0.09 | ||
| Q3 25 | $0.87 | $-0.05 | ||
| Q2 25 | $0.73 | $0.03 | ||
| Q1 25 | $0.13 | $-0.02 | ||
| Q4 24 | $0.75 | $-0.14 | ||
| Q3 24 | $0.76 | $-0.05 | ||
| Q2 24 | $0.77 | $-0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $50.0M | $6.2M |
| Total DebtLower is stronger | $21.0K | — |
| Stockholders' EquityBook value | $139.4M | $5.9M |
| Total Assets | $143.9M | $44.2M |
| Debt / EquityLower = less leverage | 0.00× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $50.0M | — | ||
| Q4 25 | $44.6M | $6.2M | ||
| Q3 25 | $48.9M | $7.5M | ||
| Q2 25 | $39.5M | $10.2M | ||
| Q1 25 | $36.9M | $11.6M | ||
| Q4 24 | $40.1M | $3.3M | ||
| Q3 24 | $40.4M | $5.7M | ||
| Q2 24 | $29.7M | $8.5M |
| Q1 26 | $21.0K | — | ||
| Q4 25 | $23.0K | — | ||
| Q3 25 | $25.0K | — | ||
| Q2 25 | $26.0K | — | ||
| Q1 25 | $29.0K | — | ||
| Q4 24 | $32.0K | — | ||
| Q3 24 | $34.0K | $13.8M | ||
| Q2 24 | $35.0K | $13.7M |
| Q1 26 | $139.4M | — | ||
| Q4 25 | $136.0M | $5.9M | ||
| Q3 25 | $134.7M | $9.0M | ||
| Q2 25 | $130.0M | $11.6M | ||
| Q1 25 | $126.0M | $14.5M | ||
| Q4 24 | $125.1M | $11.1M | ||
| Q3 24 | $122.2M | $13.4M | ||
| Q2 24 | $118.0M | $17.4M |
| Q1 26 | $143.9M | — | ||
| Q4 25 | $140.1M | $44.2M | ||
| Q3 25 | $140.7M | $45.8M | ||
| Q2 25 | $133.8M | $48.0M | ||
| Q1 25 | $128.9M | $50.8M | ||
| Q4 24 | $129.1M | $47.4M | ||
| Q3 24 | $127.0M | $47.8M | ||
| Q2 24 | $122.8M | $53.4M |
| Q1 26 | 0.00× | — | ||
| Q4 25 | 0.00× | — | ||
| Q3 25 | 0.00× | — | ||
| Q2 25 | 0.00× | — | ||
| Q1 25 | 0.00× | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | 0.00× | 1.03× | ||
| Q2 24 | 0.00× | 0.78× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $5.4M | $-4.8M |
| Free Cash FlowOCF − Capex | $5.4M | $-4.9M |
| FCF MarginFCF / Revenue | 37.0% | -53.4% |
| Capex IntensityCapex / Revenue | 0.1% | 1.2% |
| Cash ConversionOCF / Net Profit | 1.72× | — |
| TTM Free Cash FlowTrailing 4 quarters | $20.2M | $-12.5M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $5.4M | — | ||
| Q4 25 | $-4.3M | $-4.8M | ||
| Q3 25 | $9.5M | $-2.6M | ||
| Q2 25 | $10.2M | $-1.5M | ||
| Q1 25 | $-3.2M | $-3.5M | ||
| Q4 24 | $-182.0K | $-2.3M | ||
| Q3 24 | $10.7M | $-2.5M | ||
| Q2 24 | $10.7M | $-4.8M |
| Q1 26 | $5.4M | — | ||
| Q4 25 | $-4.3M | $-4.9M | ||
| Q3 25 | $9.5M | $-2.6M | ||
| Q2 25 | $9.7M | $-1.5M | ||
| Q1 25 | $-3.3M | $-3.5M | ||
| Q4 24 | $-268.0K | $-2.4M | ||
| Q3 24 | $10.7M | $-2.6M | ||
| Q2 24 | $10.3M | $-4.8M |
| Q1 26 | 37.0% | — | ||
| Q4 25 | -45.9% | -53.4% | ||
| Q3 25 | 53.2% | -27.3% | ||
| Q2 25 | 86.4% | -16.1% | ||
| Q1 25 | -43.4% | -39.7% | ||
| Q4 24 | -2.3% | -26.3% | ||
| Q3 24 | 55.8% | -30.4% | ||
| Q2 24 | 52.5% | -54.4% |
| Q1 26 | 0.1% | — | ||
| Q4 25 | 0.6% | 1.2% | ||
| Q3 25 | 0.1% | 0.2% | ||
| Q2 25 | 5.2% | 0.4% | ||
| Q1 25 | 0.3% | 0.0% | ||
| Q4 24 | 0.7% | 0.8% | ||
| Q3 24 | 0.2% | 1.8% | ||
| Q2 24 | 2.3% | 0.2% |
| Q1 26 | 1.72× | — | ||
| Q4 25 | -3.54× | — | ||
| Q3 25 | 2.03× | — | ||
| Q2 25 | 2.63× | -0.78× | ||
| Q1 25 | -4.51× | — | ||
| Q4 24 | -0.05× | — | ||
| Q3 24 | 2.63× | — | ||
| Q2 24 | 2.59× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AXR
Segment breakdown not available.
CTSO
| Direct | $5.1M | 55% |
| Distributors And Strategic Partners | $4.2M | 45% |
